GlassScriptPhysician profile
Lauren Terranova
NPI 1821363292
$950.32
in general payments reported to CMS, 2019-2025
12 companies · $536 in 2025
The $536 reported for 2025 was more than what 80% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.21 · 2022: $148 · 2023: $226 · 2024: $14.10 · 2025: $536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529 · Travel and Lodging: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.98 |
| Travel and Lodging | $246.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $392.59 | 2025 | Wavewriter Alpha Prime 16 |
| Fidia Pharma USA INC. | $122.24 | 2022 | |
| Medtronic, INC. | $111.07 | 2023-2025 | Solitaire X, Inceptiv |
| Depuy Synthes Sales INC. | $106.91 | 2023-2025 | Monovisc |
| Kerecis Limited | $56.37 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Globus Medical, INC. | $47.31 | 2025 | Senza |
| Integra Lifesciences Corporation | $26.21 | 2019 | |
| Davol INC. | $25.90 | 2022 | |
| Curonix LLC | $16.56 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $16.31 | 2025 | Nalu Neurostimulation System |
| Pacira Pharmaceuticals Incorporated | $14.75 | 2025 | Exparel |
| Bioventus LLC | $14.10 | 2024 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Terranova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.